Galaxy Surfactants Limited
NSE:GALAXYSURF.NS
2442.15 (INR) • At close January 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) INR.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 37,647.3 | 44,452.4 | 36,527.2 | 27,453.5 | 25,632.8 | 27,318.2 | 24,127.5 | 21,613.43 | 18,019.11 | 18,739.36 | 16,972.94 | 15,807.36 |
| Cost of Revenue
| 26,053 | 31,000.8 | 26,078.7 | 17,905.6 | 17,292.7 | 19,601.6 | 17,625.8 | 15,346.3 | 12,081.65 | 13,320.18 | 11,793.66 | 11,781.63 |
| Gross Profit
| 11,594.3 | 13,451.6 | 10,448.5 | 9,547.9 | 8,340.1 | 7,716.6 | 6,501.7 | 6,267.13 | 5,937.46 | 5,419.18 | 5,179.28 | 4,025.73 |
| Gross Profit Ratio
| 0.308 | 0.303 | 0.286 | 0.348 | 0.325 | 0.282 | 0.269 | 0.29 | 0.33 | 0.289 | 0.305 | 0.255 |
| Reseach & Development Expenses
| 0 | 275 | 293.4 | 269.2 | 269 | 261.1 | 260.4 | 265.8 | 121.03 | 102.75 | 0 | 0 |
| General & Administrative Expenses
| 504.8 | 445.8 | 380.8 | 377.5 | 342.5 | 233.1 | 235.5 | 252.2 | 245.67 | 220.05 | 209.37 | 181.12 |
| Selling & Marketing Expenses
| 1,617 | 2,302.7 | 2,520.1 | 1,513.7 | 1,218.4 | 1,164.6 | 851.5 | 8.05 | 3.75 | 3.25 | 2.6 | 0 |
| SG&A
| 2,964.1 | 2,748.5 | 2,900.9 | 1,891.2 | 1,560.9 | 1,397.7 | 1,087 | 260.25 | 249.42 | 223.3 | 211.97 | 181.12 |
| Other Expenses
| 0 | 98.5 | 98.6 | 45.5 | 40 | 99.9 | 39.8 | 63.38 | 29.64 | 9.61 | 6.89 | 3.33 |
| Operating Expenses
| 3,272.8 | 8,603.6 | 7,143.7 | 5,726.9 | 5,272.9 | 4,694.9 | 4,109.9 | 4,027.09 | 4,027.88 | 3,917.04 | 3,540.98 | 3,299.65 |
| Operating Income
| 8,602.3 | 4,849.3 | 3,296.5 | 3,821 | 3,067.2 | 3,021.7 | 2,391.8 | 2,240.08 | 1,909.65 | 1,502.17 | 1,638.4 | 726.17 |
| Operating Income Ratio
| 0.228 | 0.109 | 0.09 | 0.139 | 0.12 | 0.111 | 0.099 | 0.104 | 0.106 | 0.08 | 0.097 | 0.046 |
| Total Other Income Expenses Net
| -4,847.6 | -5,669.4 | -4,949.1 | -3,764.5 | -178.8 | -253.2 | -204.1 | 34.6 | -48.42 | -268.6 | -308.63 | -514.53 |
| Income Before Tax
| 3,754.7 | 4,729.5 | 3,293.1 | 3,723.2 | 2,888.4 | 2,768.5 | 2,187.7 | 2,042.87 | 1,634.88 | 1,122.9 | 1,230.42 | 188.06 |
| Income Before Tax Ratio
| 0.1 | 0.106 | 0.09 | 0.136 | 0.113 | 0.101 | 0.091 | 0.095 | 0.091 | 0.06 | 0.072 | 0.012 |
| Income Tax Expense
| 740 | 919.7 | 665.3 | 701.8 | 584.3 | 858.7 | 607.4 | 579.81 | 607.7 | 448.34 | 470.45 | 185.28 |
| Net Income
| 3,014.7 | 3,809.8 | 2,627.8 | 3,021.4 | 2,304.1 | 1,909.8 | 1,580.3 | 1,463.06 | 1,027.18 | 674.56 | 759.97 | 2.78 |
| Net Income Ratio
| 0.08 | 0.086 | 0.072 | 0.11 | 0.09 | 0.07 | 0.065 | 0.068 | 0.057 | 0.036 | 0.045 | 0 |
| EPS
| 85.03 | 107.46 | 74.12 | 85.22 | 64.99 | 53.87 | 44.57 | 41.64 | 28.97 | 19.03 | 21.43 | 0.08 |
| EPS Diluted
| 85.03 | 107.46 | 74.12 | 85.22 | 64.99 | 53.87 | 44.57 | 41.64 | 28.97 | 19.03 | 21.43 | 0.08 |
| EBITDA
| 4,976.8 | 5,780 | 4,132.2 | 4,524.7 | 3,748.3 | 3,580.5 | 2,978.5 | 2,818 | 2,330.17 | 1,856.19 | 2,221.75 | 1,237.05 |
| EBITDA Ratio
| 0.132 | 0.13 | 0.113 | 0.17 | 0.146 | 0.131 | 0.123 | 0.126 | 0.13 | 0.099 | 0.125 | 0.076 |